Enzon to Acquire North American and Japanese Rights to Elan Drug
By Business Review Editor
Pharma Deals Review: Vol 2002 Issue 29 (Table of Contents)
Published: 2 Oct-2002
DOI: 10.3833/pdr.v2002.i29.1001 ISSN: 1756-7874
Section: Distribution & Marketing
Fulltext:
Abstract
Enzon entered into an agreement to acquire North American and Japanese rights relating to Abelcet® from Elan for approximately US$370 M in cash...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS